glp 1 and crohn's Frontiers GLP-1 and GLP-2 Orchestrate Intestine

Emerging technologies and future directions are presented at the end, synthesizing how converging bioengineering and immunology can enable new therapies for neuropathology

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes and, more recently, some have been approved for weight management

Over the years, milk and water kefirs have gained a reputation for its excellent health effects that include antimicrobial (Powell et al., 2007), probiotics and improving gut health (Garrote et al., 2010), improving lactose digestion (Rattray & OConnell 2011), anticarcinogenic (Khoury et al., 2014), antioxidant (Chen et al., 2015), regulating cholesterol (Garca-Burgos et al., 2020) and more recently on controlling blood glucose level (Salari et al., 2021) through evidence of in-vitro and in-vivo researches when taken regularly at serving size typically ranging from 180 mL to 500 mL in a day (Chong et al., 2023

In a double-blind study, 40 PVD patients were given either reduced active glutathione (GSH) IV infusions twice a day or placebo

Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA

They attempt to increase the body own GLP-1 production by creating favorable conditions in the gut